Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma

Chan Yong Kim, Woon Yong Jung, Hyun Joo Lee, Han Kyeom Kim, Aeree Kim, Bong Kyung Shin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The study of tumor biomarkers was gradually facilitated by the adoption of proteomic strategies due to less invasiveness and higher sensitivity. Colorectal cancer is one of the most commonly occurring cancers worldwide and its incidence has markedly increased in Korea. While the adoption of proteomic strategies facilitated the study of tumor biomarkers, to date, no common agreement has been derived from proteomic investigations regarding tumor markers of colorectal cancer. This study was designed to find molecules differentially expressed in colorectal cancer compared to non-tumor mucosa. Four colorectal adenocarcinoma and corresponding non-tumor tissue samples were analyzed to find previously unknown proteins via two-dimensional electrophoresis and MALDI-TOF/MS spectrometry. Western blot assays and tissue microarray (TMA) immunohistochemistry were performed to validate the identified proteins. Among the twelve up-regulated and one down-regulated proteins identified, moesin, cytokeratin (KRT) 17 and carbonic anhydrase I were validated by Western blot analysis and/or immunohistochemistry. On immunohistochemistry, both moesin and KRT17 demonstrated a tendency of increased expression as pT stage advanced. Both moesin and KRT17 were not expressed in normal colorectal epithelium. These two proteins may play a role in cancer invasion and/or metastasis in colorectal carcinoma, and could be candidate biomarkers for the diagnosis and prognosis of colorectal cancer.

Original languageEnglish
Pages (from-to)608-620
Number of pages13
JournalOncology Reports
Volume27
Issue number3
DOIs
Publication statusPublished - 2012 Mar 1

Fingerprint

Keratin-17
Proteomics
Colorectal Neoplasms
Tumor Biomarkers
Immunohistochemistry
Proteins
Western Blotting
Carbonic Anhydrase I
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Korea
Electrophoresis
Neoplasms
Spectrum Analysis
Mucous Membrane
Adenocarcinoma
Epithelium
Biomarkers
moesin
Neoplasm Metastasis
Incidence

Keywords

  • 2-dimensional electrophoresis
  • Colorectal carcinoma
  • Cytokeratin 17
  • Mass spectrometry
  • Moesin
  • Proteomics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma. / Kim, Chan Yong; Jung, Woon Yong; Lee, Hyun Joo; Kim, Han Kyeom; Kim, Aeree; Shin, Bong Kyung.

In: Oncology Reports, Vol. 27, No. 3, 01.03.2012, p. 608-620.

Research output: Contribution to journalArticle

@article{5e40b1071f2e44a0a71254338f2c49c7,
title = "Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma",
abstract = "The study of tumor biomarkers was gradually facilitated by the adoption of proteomic strategies due to less invasiveness and higher sensitivity. Colorectal cancer is one of the most commonly occurring cancers worldwide and its incidence has markedly increased in Korea. While the adoption of proteomic strategies facilitated the study of tumor biomarkers, to date, no common agreement has been derived from proteomic investigations regarding tumor markers of colorectal cancer. This study was designed to find molecules differentially expressed in colorectal cancer compared to non-tumor mucosa. Four colorectal adenocarcinoma and corresponding non-tumor tissue samples were analyzed to find previously unknown proteins via two-dimensional electrophoresis and MALDI-TOF/MS spectrometry. Western blot assays and tissue microarray (TMA) immunohistochemistry were performed to validate the identified proteins. Among the twelve up-regulated and one down-regulated proteins identified, moesin, cytokeratin (KRT) 17 and carbonic anhydrase I were validated by Western blot analysis and/or immunohistochemistry. On immunohistochemistry, both moesin and KRT17 demonstrated a tendency of increased expression as pT stage advanced. Both moesin and KRT17 were not expressed in normal colorectal epithelium. These two proteins may play a role in cancer invasion and/or metastasis in colorectal carcinoma, and could be candidate biomarkers for the diagnosis and prognosis of colorectal cancer.",
keywords = "2-dimensional electrophoresis, Colorectal carcinoma, Cytokeratin 17, Mass spectrometry, Moesin, Proteomics",
author = "Kim, {Chan Yong} and Jung, {Woon Yong} and Lee, {Hyun Joo} and Kim, {Han Kyeom} and Aeree Kim and Shin, {Bong Kyung}",
year = "2012",
month = "3",
day = "1",
doi = "10.3892/or.2011.1545",
language = "English",
volume = "27",
pages = "608--620",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma

AU - Kim, Chan Yong

AU - Jung, Woon Yong

AU - Lee, Hyun Joo

AU - Kim, Han Kyeom

AU - Kim, Aeree

AU - Shin, Bong Kyung

PY - 2012/3/1

Y1 - 2012/3/1

N2 - The study of tumor biomarkers was gradually facilitated by the adoption of proteomic strategies due to less invasiveness and higher sensitivity. Colorectal cancer is one of the most commonly occurring cancers worldwide and its incidence has markedly increased in Korea. While the adoption of proteomic strategies facilitated the study of tumor biomarkers, to date, no common agreement has been derived from proteomic investigations regarding tumor markers of colorectal cancer. This study was designed to find molecules differentially expressed in colorectal cancer compared to non-tumor mucosa. Four colorectal adenocarcinoma and corresponding non-tumor tissue samples were analyzed to find previously unknown proteins via two-dimensional electrophoresis and MALDI-TOF/MS spectrometry. Western blot assays and tissue microarray (TMA) immunohistochemistry were performed to validate the identified proteins. Among the twelve up-regulated and one down-regulated proteins identified, moesin, cytokeratin (KRT) 17 and carbonic anhydrase I were validated by Western blot analysis and/or immunohistochemistry. On immunohistochemistry, both moesin and KRT17 demonstrated a tendency of increased expression as pT stage advanced. Both moesin and KRT17 were not expressed in normal colorectal epithelium. These two proteins may play a role in cancer invasion and/or metastasis in colorectal carcinoma, and could be candidate biomarkers for the diagnosis and prognosis of colorectal cancer.

AB - The study of tumor biomarkers was gradually facilitated by the adoption of proteomic strategies due to less invasiveness and higher sensitivity. Colorectal cancer is one of the most commonly occurring cancers worldwide and its incidence has markedly increased in Korea. While the adoption of proteomic strategies facilitated the study of tumor biomarkers, to date, no common agreement has been derived from proteomic investigations regarding tumor markers of colorectal cancer. This study was designed to find molecules differentially expressed in colorectal cancer compared to non-tumor mucosa. Four colorectal adenocarcinoma and corresponding non-tumor tissue samples were analyzed to find previously unknown proteins via two-dimensional electrophoresis and MALDI-TOF/MS spectrometry. Western blot assays and tissue microarray (TMA) immunohistochemistry were performed to validate the identified proteins. Among the twelve up-regulated and one down-regulated proteins identified, moesin, cytokeratin (KRT) 17 and carbonic anhydrase I were validated by Western blot analysis and/or immunohistochemistry. On immunohistochemistry, both moesin and KRT17 demonstrated a tendency of increased expression as pT stage advanced. Both moesin and KRT17 were not expressed in normal colorectal epithelium. These two proteins may play a role in cancer invasion and/or metastasis in colorectal carcinoma, and could be candidate biomarkers for the diagnosis and prognosis of colorectal cancer.

KW - 2-dimensional electrophoresis

KW - Colorectal carcinoma

KW - Cytokeratin 17

KW - Mass spectrometry

KW - Moesin

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=84863036601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863036601&partnerID=8YFLogxK

U2 - 10.3892/or.2011.1545

DO - 10.3892/or.2011.1545

M3 - Article

C2 - 22076435

AN - SCOPUS:84863036601

VL - 27

SP - 608

EP - 620

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -